Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-Term Fasting Prior to Standard Checkpoint Blockade Using PD-1/PD-L1 Inhibition: A Pilot Safety and Feasibility Study

NCT04387084 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT04387084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04387084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-Term Fasting Prior to Standard Checkpoint Blockade Using PD-1/PD-L1 Inhibition: A Pilot Safety and Feasibility Study
Lead sponsor
University of Southern California
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 12, 2020
Completion date
March 31, 2028
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant skin neoplasm, metastatic malignant skin neoplasm